- Home
- AARD vs AMPY Comparison
AARD vs AMPY Comparison
Compare AARD & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AARD | AMPY |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.1M | 246.9M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | AARD | AMPY |
|---|---|---|
| Price | $5.07 | $6.53 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $19.63 | N/A |
| AVG Volume (30 Days) | 375.2K | ★ 835.6K |
| Earning Date | 01-01-0001 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 232.26 |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | ★ $208,637,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $5.88 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.74 | $2.27 |
| 52 Week High | $17.94 | $6.55 |
Technical Indicators
Market Signals| Indicator | AARD | AMPY |
|---|---|---|
| Relative Strength Index (RSI) | 22.62 | 65.32 |
| Support Level | $4.74 | $4.40 |
| Resistance Level | $15.88 | $6.55 |
| Average True Range (ATR) | 0.54 | 0.45 |
| MACD | -0.33 | 0.02 |
| Stochastic Oscillator | 4.23 | 85.71 |
Price Performance
Historical ComparisonAbout AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.